Bayer Says It Disagrees With US Supreme Court on Weedkiller Ruling
21 Giugno 2022 - 4:31PM
Dow Jones News
By Ed Frankl
Bayer AG said Tuesday that it "respectfully disagrees" with the
U.S. Supreme Court's decision to decline to hear a review of a case
that found that the company's weedkiller Roundup may have caused a
Calfornia man's cancer.
The German conglomerate said the Supreme Court's decision not to
hear a review of a previous case that awarded Edwin Hardeman $25
million undermines the ability of companies to rely on official
actions taken by expert regulatory agencies.
A positive result for Bayer at the Supreme Court could have
ended thousands of pending lawsuits against the company.
"Bayer continues to stand fully behind its Roundup products
which are a valuable tool in efficient agricultural production
around the world," it said.
The Leverkusen-based company said it is prepared to manage the
litigation risk associated with potential future claims in the
U.S.
Bayer took a provision in the second quarter of 2021 of $4.5
billion, in addition to the $2 billion previously taken, it
said.
Write to Ed Frankl at edward.frankl@dowjones.com
(END) Dow Jones Newswires
June 21, 2022 10:16 ET (14:16 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Grafico Azioni Bayer (TG:BAYN)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Bayer (TG:BAYN)
Storico
Da Apr 2023 a Apr 2024